{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-4226"},"canonical_url":"https://search.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-4226","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"Investigating the Antibacterial and Immunomodulatory Effects of Resolvin D2 on Monocytes and Macrophages","abstract":"In the late phase of sepsis, immunosuppression occurs, where the host is unable to clear the pre-existing infection and is susceptible to secondary infections. It is believed that the ideal treatments for sepsis should attenuate immunosuppression so that the host can get back to homeostasis. Specialized Pro-resolving Mediators (SPMs) are endogenously- produced fatty acids that resolve infectious inflammation without being immunosuppressive. We hypothesize that an SPM – Resolvin D2 (RvD2) – can augment exhausted macrophage function during the immunosuppressive phase of sepsis. We developed a two-hit model to establish macrophage exhaustion in vitro, and found that RvD2 increased NF-κB activity, TNF-α release, and bacterial clearance in exhausted macrophages compared to controls. Toll-like receptor-2 (TLR2) inhibition abolished RvD2-mediated changes in exhausted macrophages. In a mouse sepsis model, splenic macrophage response to exogenous LPS was reduced compared to controls and was restored by in vivo administration of RvD2. However, if RvD2 was added to monocytes before differentiation to macrophages, RvD2 reduced LPS responses and increased bacterial clearance. The results showed that RvD2 can attenuate macrophage suppression in vitro and in vivo and that this effect was macrophage-specific.","abstract_html":"In the late phase of sepsis, immunosuppression occurs, where the host is unable to clear the pre-existing infection and is susceptible to secondary infections. It is believed that the ideal treatments for sepsis should attenuate immunosuppression so that the host can get back to homeostasis. Specialized Pro-resolving Mediators (SPMs) are endogenously- produced fatty acids that resolve infectious inflammation without being immunosuppressive. We hypothesize that an SPM – Resolvin D2 (RvD2) – can augment exhausted macrophage function during the immunosuppressive phase of sepsis. We developed a two-hit model to establish macrophage exhaustion in vitro, and found that RvD2 increased NF-κB activity, TNF-α release, and bacterial clearance in exhausted macrophages compared to controls. Toll-like receptor-2 (TLR2) inhibition abolished RvD2-mediated changes in exhausted macrophages. In a mouse sepsis model, splenic macrophage response to exogenous LPS was reduced compared to controls and was restored by in vivo administration of RvD2. However, if RvD2 was added to monocytes before differentiation to macrophages, RvD2 reduced LPS responses and increased bacterial clearance. The results showed that RvD2 can attenuate macrophage suppression in vitro and in vivo and that this effect was macrophage-specific.","abstract_has_math":false,"creators":["Padovani, Cristina Maria"],"institution":null,"degree_name":"Doctor of Philosophy (Ph.D.)","degree_level":"Dissertation","degree_discipline":"Cell Biology and Neuroscience","degree_department":null,"school":null,"contributors":["Kingsley Yin, Ph.D.","Jessica Loweth, Ph.D.","Bernd Spur, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:59:52Z","subjects":["immunosuppression; macrophages; NF-κB; Pseudomonas aeruginosa; sepsis; THP-1 cells","Septicemia--Treatment","Cell Biology","Neuroscience and Neurobiology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/3220","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://rdw.rowan.edu/etd/3220","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://rdw.rowan.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ardw.rowan.edu%3Aetd-4226","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Kingsley Yin, Ph.D.","Jessica Loweth, Ph.D.","Bernd Spur, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Padovani, Cristina Maria"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-05-06T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2024-05-06T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Cell Biology and Neuroscience"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (Ph.D.)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["immunosuppression; macrophages; NF-κB; Pseudomonas aeruginosa; sepsis; THP-1 cells","Septicemia--Treatment","Cell Biology","Neuroscience and Neurobiology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/3220"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["In the late phase of sepsis, immunosuppression occurs, where the host is unable to clear the pre-existing infection and is susceptible to secondary infections. It is believed that the ideal treatments for sepsis should attenuate immunosuppression so that the host can get back to homeostasis. Specialized Pro-resolving Mediators (SPMs) are endogenously- produced fatty acids that resolve infectious inflammation without being immunosuppressive. We hypothesize that an SPM – Resolvin D2 (RvD2) – can augment exhausted macrophage function during the immunosuppressive phase of sepsis. We developed a two-hit model to establish macrophage exhaustion in vitro, and found that RvD2 increased NF-κB activity, TNF-α release, and bacterial clearance in exhausted macrophages compared to controls. Toll-like receptor-2 (TLR2) inhibition abolished RvD2-mediated changes in exhausted macrophages. In a mouse sepsis model, splenic macrophage response to exogenous LPS was reduced compared to controls and was restored by in vivo administration of RvD2. However, if RvD2 was added to monocytes before differentiation to macrophages, RvD2 reduced LPS responses and increased bacterial clearance. The results showed that RvD2 can attenuate macrophage suppression in vitro and in vivo and that this effect was macrophage-specific."]},{"key":"dc:title","label":"Title","values":["Investigating the Antibacterial and Immunomodulatory Effects of Resolvin D2 on Monocytes and Macrophages"]}]}],"canonical_facts":{"dc:contributor":["Kingsley Yin, Ph.D.","Jessica Loweth, Ph.D.","Bernd Spur, Ph.D."],"dc:creator":["Padovani, Cristina Maria"],"dc:date.available":["2024-05-06T07:00:00Z"],"dc:date.created":["2024-05-06T07:00:00Z"],"dc:description.abstract":["In the late phase of sepsis, immunosuppression occurs, where the host is unable to clear the pre-existing infection and is susceptible to secondary infections. It is believed that the ideal treatments for sepsis should attenuate immunosuppression so that the host can get back to homeostasis. Specialized Pro-resolving Mediators (SPMs) are endogenously- produced fatty acids that resolve infectious inflammation without being immunosuppressive. We hypothesize that an SPM – Resolvin D2 (RvD2) – can augment exhausted macrophage function during the immunosuppressive phase of sepsis. We developed a two-hit model to establish macrophage exhaustion in vitro, and found that RvD2 increased NF-κB activity, TNF-α release, and bacterial clearance in exhausted macrophages compared to controls. Toll-like receptor-2 (TLR2) inhibition abolished RvD2-mediated changes in exhausted macrophages. In a mouse sepsis model, splenic macrophage response to exogenous LPS was reduced compared to controls and was restored by in vivo administration of RvD2. However, if RvD2 was added to monocytes before differentiation to macrophages, RvD2 reduced LPS responses and increased bacterial clearance. The results showed that RvD2 can attenuate macrophage suppression in vitro and in vivo and that this effect was macrophage-specific."],"dc:identifier":["https://rdw.rowan.edu/etd/3220"],"dc:subject":["immunosuppression; macrophages; NF-κB; Pseudomonas aeruginosa; sepsis; THP-1 cells","Septicemia--Treatment","Cell Biology","Neuroscience and Neurobiology"],"dc:title":["Investigating the Antibacterial and Immunomodulatory Effects of Resolvin D2 on Monocytes and Macrophages"],"thesis:degree_discipline":["Cell Biology and Neuroscience"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Doctor of Philosophy (Ph.D.)"]},"updated_at":"2026-11-19T08:59:52Z"}